Cullinan Oncology LLC (CGEM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $667.39M
Last updated: Nov 17, 2026 at 4:20 PM ET
Cullinan Oncology LLC (CGEM) Stock Chart
Cullinan Oncology LLC (CGEM) has a latest price of $9.28 on Nov 17, 2026, 60.0% below its 52-week high of $23.19. Its price rose 8.5% over the past 12 months. The month-end price fell 32.4% over the 5 years through Oct 2026, a compound annual decline of 7.5%.
Price Chart
From Jan 2021 to Oct 2026, its highest month-end close was $41.67 in Mar 2021 and its lowest $5.93 in Sep 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CGEM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CGEM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 58.8%, and over 6 months it fell 34.6%. The month-end price rose 61.1% over the 3 years through Oct 2026, a compound annual rate of 17.2%.
| Period | Change |
|---|---|
| 1 month | -33.7% |
| 3 months | -58.8% |
| 6 months | -34.6% |
| 12 months | +8.5% |
| 12 months, with dividends | +8.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +61.1% | +17.2% |
| 5 years | -32.4% | -7.5% |
Price by Year
Its best calendar year was 2024, when the price rose 19.5%, and its weakest was 2022, when it fell 31.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $15.03 | +45.2% |
| 2025 | $10.35 | -15.0% |
| 2024 | $12.18 | +19.5% |
| 2023 | $10.19 | -3.4% |
| 2022 | $10.55 | -31.6% |
Trading Range
The price is 39.6% below its 50-day average of $15.37 and 41.3% below its 200-day average of $15.79.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.28 | |
| 52-week high | $23.19 | -60.0% |
| 52-week low | $8.23 | +12.7% |
| 50-day average | $15.37 | -39.6% |
| 200-day average | $15.79 | -41.3% |
Price Risk
Over 3 years, its largest fall from a peak was 80.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.64 |
| Largest fall, 1 year | -59.6% |
| Largest fall, 3 years | -80.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CGEM
What is CGEM's 1-year price change?
Cullinan Oncology LLC's price rose 8.5% over the past 12 months. With dividends included, the 12-month total return was 8.5%.
What is CGEM's 5-year price change?
Cullinan Oncology LLC's month-end price fell 32.4% over the 5 years through Oct 2026, a compound annual decline of 7.5%. These figures leave out dividends.
What is CGEM's 52-week high and low?
Cullinan Oncology LLC's 52-week high is $23.19 and its 52-week low is $8.23. Its latest price of $9.28 on Nov 17, 2026 is 60.0% below the high.
What is CGEM's beta?
Cullinan Oncology LLC's 1-year beta against the S&P 500 is 1.64, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.6%.
Is the CGEM chart free?
Yes. Advanced Charting for CGEM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CGEM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors